The treatment for metastatic renal cell carcinoma
10.3760/cma.j.cn112330-20200506-00356
- VernacularTitle:转移性肾癌的治疗
- Author:
Peng HONG
1
;
Zhuo LIU
;
Cheng LIU
;
Xiaojun TIAN
;
Guoliang WANG
;
Shudong ZHANG
;
Lulin MA
Author Information
1. 北京大学第三医院泌尿外科 100191
- From:
Chinese Journal of Urology
2020;41(6):474-476
- CountryChina
- Language:Chinese
-
Abstract:
The prognosis of metastatic renal cell carcinoma is relatively poor. With the development of molecular biology, the treatment of metastatic renal cell carcinoma is undergoing a transformation from cytokine therapy to targeted molecular therapy or immunotherapy, and the prognosis has been improved. This study summarized and discussed the treatment progress of metastatic renal cell carcinoma.